SQZ Biotechnologies Co:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SQZ Biotechnologies Co - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10967
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SQZ Biotechnologies Co (SQZ) develops cell-based therapies that harness the body’s natural immune system against cancer. The company utilizes CellSqueeze, a technology platform for engineering various cell functions as antigen presenting cells (APCs) for immune modulation to impact oncology and autoimmune disease applications. SQZ’s APC approach enables delivery of cancer-specific antigens to the cytosol of the APC which generates polyclonal T cell responses. The company works in partnership with other academic institutions, pharmaceutical and biotechnology companies focusing on developing new cell therapies and approaches for that transform patient lives. SQZ is headquartered in Watertown, Massachusetts, the US.

SQZ Biotechnologies Co – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
SQZ Biotech Raises USD72 Million in Series C Financing 10
SQZ Biotech Raises Funds through Venture Financing 12
SQZ Biotech Raises Additional USD4 Million in Series B Financing 13
SQZ Biotech Raises USD16 Million in Series B Financing 14
SQZ Biotech Raises USD5 Million in Series A Venture Financing 15
SQZ Biotechnologies Raises Funds through Venture Financing 16
Partnerships 17
Roche Expands Agreement with SQZ Biotech 17
Licensing Agreements 18
SQZ Biotec Enters into License Agreement with Massachusetts Institute of Technology 18
SQZ Biotechnologies Co – Key Competitors 19
SQZ Biotechnologies Co – Key Employees 20
SQZ Biotechnologies Co – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Sep 27, 2018: SQZ Biotech Announces Key Executive and Board of Directors Appointments 22
Aug 23, 2017: SQZ Biotech Expands Leadership Team, Appoints Shefali Agarwal, MD, MPH, as Chief Medical Officer 23
Other Significant Developments 24
May 14, 2018: SQZ Biotech CEO to Participate in BIO International Panel and to Present at Investor Conferences in Second Quarter 2018 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Key Facts 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SQZ Biotechnologies Co, Deals By Therapy Area, 2012 to YTD 2018 8
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SQZ Biotech Raises USD72 Million in Series C Financing 10
SQZ Biotech Raises Funds through Venture Financing 12
SQZ Biotech Raises Additional USD4 Million in Series B Financing 13
SQZ Biotech Raises USD16 Million in Series B Financing 14
SQZ Biotech Raises USD5 Million in Series A Venture Financing 15
SQZ Biotechnologies Raises Funds through Venture Financing 16
Roche Expands Agreement with SQZ Biotech 17
SQZ Biotec Enters into License Agreement with Massachusetts Institute of Technology 18
SQZ Biotechnologies Co, Key Competitors 19
SQZ Biotechnologies Co, Key Employees 20

List of Figures
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SQZ Biotechnologies Co:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pegatron Corporation:企業の戦略・SWOT・財務情報
    Pegatron Corporation - Strategy, SWOT and Corporate Finance Report Summary Pegatron Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Southwire Company, LLC:企業の戦略・SWOT・財務情報
    Southwire Company, LLC - Strategy, SWOT and Corporate Finance Report Summary Southwire Company, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Calpine Corporation (CPN)-エネルギー分野:企業M&A・提携分析
    Summary Calpine Corporation (Calpine) is an electric and natural gas utility. The company produces electricity and thermal energy from natural gas, geothermal, and solar sources. It uses natural gas-fired combustion and renewable geothermal conventional steam turbine technologies to generate energy. …
  • Bharat Road Network Limited (BRNL):企業の財務・戦略的SWOT分析
    Bharat Road Network Limited (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • BroadSoft Inc.:企業のM&A・事業提携・投資動向
    BroadSoft Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BroadSoft Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • LivePerson Inc (LPSN):企業の財務・戦略的SWOT分析
    LivePerson Inc (LPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Imperial Oil Ltd (IMO):企業の財務・戦略的SWOT分析
    Imperial Oil Ltd (IMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • JP Elektroprivreda BiH d.d. Sarajevo (JPESR)-エネルギー分野:企業M&A・提携分析
    Summary JP Elektroprivreda BiH d.d. Sarajevo (Elektroprivreda BiH) is a utility company that generates, transmits, supplies, and trades electricity. It also exports and imports electricity, including the management of electricity system. The company generates electricity from coal and hydro sources. …
  • IndusInd Bank Ltd:企業の戦略・SWOT・財務情報
    IndusInd Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary IndusInd Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Enbridge Energy Partners LP (EEP)-石油・ガス分野:企業M&A・提携分析
    Summary Enbridge Energy Partners, L.P. (EEP) is an independent midstream energy company. The company owns and operates crude oil and liquid petroleum transportation and storage assets, and natural gas gathering, treating, processing, transportation and marketing assets in the US. Its portfolio of as …
  • NetSol Technologies, Inc. (NTWK):企業の財務・戦略的SWOT分析
    NetSol Technologies, Inc. (NTWK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Symic Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops new therapeutics focused on matrix biology. The company’s pipeline products include SB-030 and SB-061. Its SB-030 is a clinical candidate used for the prevention of peripheral vascular diseases or vein graft …
  • PNM Resources, Inc.:企業の戦略・SWOT・財務分析
    PNM Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary PNM Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • One Call Care Management Inc:医療機器:M&Aディール及び事業提携情報
    Summary One Call Care Management Inc (OCCM), formerly One Call Medical Inc, is a healthcare technology provider that provides specialized cost containment services. The company offers diagnostics, dental, transport, complex home care, equipment and physical therapy, among others. It provides value a …
  • TransCanada Corporation (TRP):電力:M&Aディール及び事業提携情報
    Summary TransCanada Corp (TransCanada) is an energy infrastructure company. It develops and operates energy infrastructure, such as natural gas and liquids pipelines, power generation and gas storage facilities. The company also provides gas storage related services and operates in the regulated and …
  • Insurance Australia Group Limited:企業のM&A・事業提携・投資動向
    Insurance Australia Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Insurance Australia Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Cara Therapeutics Inc (CARA):医療機器:M&Aディール及び事業提携情報
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • Transocean Ltd.:企業の戦略・SWOT・財務情報
    Transocean Ltd. - Strategy, SWOT and Corporate Finance Report Summary Transocean Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Consolidated Edison Company of New York Inc:企業の戦略的SWOT分析
    Consolidated Edison Company of New York Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Allergan Plc (AGN)-製薬・医療分野:企業M&A・提携分析
    Summary Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆